Risk of malignant outcome in patients with wolff-parkinson-white syndrome: results of 28-years prospective electrophysiological follow-up study

Medicine and Dentistry

• Patient 100%
• Follow up 38%
• Athletes 19%
• Catheter Ablation 19%
• Atrial Fibrillation 14%
• Rest 14%
• Complication 9%
• Surgery 9%
• Combination Therapy 9%
• Wolff-Parkinson-White Syndrome 9%
• Effective Refractory Period 9%
• RR Interval 9%
• Antiarrhythmic Agent 4%
• Exercise 4%
• Evaluation Study 4%
• Accessory Pathway 4%
• Heart Atrium Pacing 4%
• Supine Position 4%
• Antidromic 4%
• Atrioventricular Node 4%
• Standing 4%
• Mortality 4%
• Inpatient 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Risk Assessment 28%
• Atrial Fibrillation 14%
• Complication 9%
• Prospective Study 9%
• Wolff Parkinson White Syndrome 9%
• Prognosis 4%
• Antiarrhythmic Agent 4%
• Death 4%
• Mortality 4%